Cas no 951884-46-1 (1-(2-Bromophenylsulfonyl)-1H-imidazole)
1-(2-Bromophenylsulfonyl)-1H-imidazole Chemical and Physical Properties
Names and Identifiers
-
- 1-(2-BROMOPHENYLSULFONYL)-1H-IMIDAZOLE
- 1-((2-Bromophenyl)sulfonyl)-1H-imidazole
- 1-(2-bromophenyl)sulfonylimidazole
- MFCD09800984
- 1-[(2-Bromophenyl)sulphonyl]-1H-imidazole
- AKOS015835118
- CS-0205619
- BS-22595
- 1-(2-Bromobenzene-1-sulfonyl)-1H-imidazole
- BNB88446
- 1-(2-bromophenylsulfonyl)-1-H-imidazole
- A859173
- DTXSID00650029
- 1-(2-bromobenzenesulfonyl)-1H-imidazole
- 951884-46-1
- 1-(2-bromobenzenesulfonyl)imidazole
- SCHEMBL25350141
- 1-(2-Bromophenylsulfonyl)-1H-imidazole
-
- MDL: MFCD09800984
- Inchi: 1S/C9H7BrN2O2S/c10-8-3-1-2-4-9(8)15(13,14)12-6-5-11-7-12/h1-7H
- InChI Key: QIVUMNUGQQBILC-UHFFFAOYSA-N
- SMILES: BrC1C=CC=CC=1S(N1C=NC=C1)(=O)=O
Computed Properties
- Exact Mass: 285.94100
- Monoisotopic Mass: 285.94116g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 15
- Rotatable Bond Count: 2
- Complexity: 315
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 1.9
- Topological Polar Surface Area: 60.3?2
Experimental Properties
- PSA: 60.34000
- LogP: 2.96340
1-(2-Bromophenylsulfonyl)-1H-imidazole Customs Data
- HS CODE:2933290090
- Customs Data:
China Customs Code:
2933290090Overview:
2933290090. Other compounds with non fused imidazole ring in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
1-(2-Bromophenylsulfonyl)-1H-imidazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 212865-1g |
1-((2-Bromophenyl)sulfonyl)-1H-imidazole |
951884-46-1 | 95% | 1g |
£76.00 | 2022-03-01 | |
| Fluorochem | 212865-5g |
1-((2-Bromophenyl)sulfonyl)-1H-imidazole |
951884-46-1 | 95% | 5g |
£225.00 | 2022-03-01 | |
| Fluorochem | 212865-10g |
1-((2-Bromophenyl)sulfonyl)-1H-imidazole |
951884-46-1 | 95% | 10g |
£400.00 | 2022-03-01 | |
| Chemenu | CM187023-10g |
1-((2-Bromophenyl)sulfonyl)-1H-imidazole |
951884-46-1 | 95% | 10g |
$284 | 2021-08-05 | |
| TRC | B698623-100mg |
1-(2-Bromophenylsulfonyl)-1H-imidazole |
951884-46-1 | 100mg |
$ 64.00 | 2023-04-18 | ||
| TRC | B698623-250mg |
1-(2-Bromophenylsulfonyl)-1H-imidazole |
951884-46-1 | 250mg |
$ 75.00 | 2023-04-18 | ||
| TRC | B698623-500mg |
1-(2-Bromophenylsulfonyl)-1H-imidazole |
951884-46-1 | 500mg |
$ 87.00 | 2023-04-18 | ||
| TRC | B698623-1g |
1-(2-Bromophenylsulfonyl)-1H-imidazole |
951884-46-1 | 1g |
$ 98.00 | 2023-04-18 | ||
| Alichem | A069003384-10g |
1-((2-Bromophenyl)sulfonyl)-1H-imidazole |
951884-46-1 | 95% | 10g |
$400.00 | 2023-08-31 | |
| Apollo Scientific | OR11570-1g |
1-[(2-Bromophenyl)sulphonyl]-1H-imidazole |
951884-46-1 | 98% | 1g |
£115.00 | 2023-09-02 |
1-(2-Bromophenylsulfonyl)-1H-imidazole Related Literature
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
-
Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
-
Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
-
Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
Additional information on 1-(2-Bromophenylsulfonyl)-1H-imidazole
Recent Advances in the Study of 1-(2-Bromophenylsulfonyl)-1H-imidazole (CAS: 951884-46-1)
1-(2-Bromophenylsulfonyl)-1H-imidazole (CAS: 951884-46-1) is a sulfonyl imidazole derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential as a versatile scaffold for drug discovery. Recent studies have explored its applications in enzyme inhibition, antimicrobial activity, and as a precursor for more complex bioactive molecules. This research brief provides an overview of the latest findings related to this compound, highlighting its synthesis, biological activities, and potential therapeutic applications.
The synthesis of 1-(2-Bromophenylsulfonyl)-1H-imidazole has been optimized in recent studies to improve yield and purity. A 2023 publication in the Journal of Medicinal Chemistry detailed a novel one-pot synthesis method that reduces the number of steps and minimizes byproduct formation. This method employs a palladium-catalyzed coupling reaction, which has been shown to enhance the efficiency of the synthesis process. The improved synthetic route is expected to facilitate further pharmacological studies and scale-up production for preclinical testing.
In terms of biological activity, 1-(2-Bromophenylsulfonyl)-1H-imidazole has demonstrated promising inhibitory effects against several enzymes, including carbonic anhydrase and histone deacetylase (HDAC). A study published in Bioorganic & Medicinal Chemistry Letters (2024) reported that this compound exhibits selective inhibition of HDAC6, an isoform implicated in various cancers and neurodegenerative diseases. The researchers utilized molecular docking and kinetic assays to elucidate the binding mode and inhibitory mechanism, providing a foundation for the development of HDAC6-targeted therapies.
Additionally, 1-(2-Bromophenylsulfonyl)-1H-imidazole has shown antimicrobial properties against a range of Gram-positive and Gram-negative bacteria. A 2023 study in Antimicrobial Agents and Chemotherapy highlighted its efficacy against methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli, with minimum inhibitory concentrations (MICs) comparable to existing antibiotics. The compound's mechanism of action appears to involve disruption of bacterial cell membrane integrity, as evidenced by electron microscopy and fluorescence assays.
Beyond its direct biological activities, 1-(2-Bromophenylsulfonyl)-1H-imidazole serves as a key intermediate in the synthesis of more complex molecules. Recent work published in Organic Letters (2024) described its use in the construction of imidazole-containing macrocycles, which exhibit enhanced binding affinity for protein targets. These macrocycles are being explored as potential candidates for treating inflammatory diseases and certain types of cancer.
In conclusion, 1-(2-Bromophenylsulfonyl)-1H-imidazole (CAS: 951884-46-1) represents a multifunctional compound with significant potential in drug discovery and development. Its optimized synthesis, diverse biological activities, and utility as a synthetic intermediate underscore its value in chemical biology and medicinal chemistry. Future research should focus on further elucidating its pharmacological profile and exploring its therapeutic applications in greater depth.
951884-46-1 (1-(2-Bromophenylsulfonyl)-1H-imidazole) Related Products
- 2232-08-8(1-(p-Toluenesulfonyl)imidazole)
- 5510-05-4(1-[(2,4-dibromophenyl)sulfonyl]-1H-benzimidazole)
- 1056454-92-2(1-(3-bromo-benzenesulfonyl)-2-methyl-1H-imidazole)
- 7189-59-5(1H-IMIDAZOLE, 1-[(4-AMINOPHENYL)SULFONYL]-)
- 112062-97-2(1H-Imidazole, 1-(1-naphthalenylsulfonyl)-)
- 152940-76-6(1-(4-bromobenzenesulfonyl)-1H-imidazole)
- 5510-12-3(1-[(2-bromo-4-chlorophenyl)sulfonyl]-2-methyl-1H-imidazole)
- 324776-97-8(1-(4-bromobenzenesulfonyl)-2-methyl-1H-imidazole)
- 951884-07-4(1-(2-Bromophenylsulfonyl)-4-methyl-1H-imidazole)
- 46248-01-5(1-(Phenylsulfonyl)-1H-imidazole)